Get started

LABU

Bullish Divergence Watchlist. LABU. Is there any particular setup people would like to see me posting consistently? I don't want to leave people behind when I start doing something different. And you would be helping me too because it's always beneficial to make sure the fundamentals are solid. If you have a concept you'd like me to work through please leave a message below. No one is asking me to do anything at this point in time so you would be first in line. I get tired of bossing myself around sometimes. Sometimes though, ok, please let's keep it civil if at all possible.
AMEX:LABULong
by emehoke
7
Symmetrical Triangle BreakoutEYPT chart is building up for another run. Potential catalyst before year end with an sNDA for Short Duration Yutiq. accumulation has been slow and steady indicating EYPT oversold conditions. Technical's: weekly chart --> Harmonic Gartley (bounced off significant support level) and been in uptrend since. Symmetrical Triangle/ Breakout setup has been known to act as a pre-courser to huge upside moves (40%+). Bull flag building in the symmetrical triangle. . . Read the rest then check out the rest of our trade ideas HERE Disclosure: I am long EYPT. I am not a financial advisor and this is not a buy/ sell recommendation but for education purposes only. Please do your homework before investing.
NASDAQ:EYPTLong
by follow_the_money
#VolatilityWatch Solid BioscencesBiotech buyouts have been very strong, especially with Gene therapy stocks as of late. Bounced off Lower end of channel Gartley pattern bounced off 1.618 fib extension along with important reversal leg of Elliott Wave Theory. if price holds inside the lower end of the channel there is a potential move back up and test the gap. looking for nice $0.40+ swing from current level. Disclosure: I am long SLDB. I may buy/ sell within the next 72 hours. I am not a financial adviser. Please do your homework before investing.
NASDAQ:SLDBLong
by follow_the_money
Build Positions in BiotechAs the month of October begins and broader markets sold off, Biotech sectors are still negative/ flat for the year. Market headlines from high prescription drug prices and lawsuits regarding the opioid epidemic have plagued some of the IBB's largest holdings; which have held biotech ETF's down while the S&P reached all time highs. Fast-Track Synopsis: Biotech is a known high volatility trading environment; More Investors will become "Traders" with new $0 trading fee platforms from Schwab and TD Ameritrade. Once people begin trading stocks, they will find that high volatility is how the "big" day-trade/ swing trading money is made. New Med-tech and Biotechnology therapies (i.e. gene therapies, NASH/ NAFLD) are ripening and getting closer to approval. There are currently over 240 biotechnology companies with Gene therapy IP IP has been growing with RMAT and Breakthrough Designations due to unmet need of new novel treatments; As Biotech rolls into year-end, lower interest rates will propel company growth models which I believe will help drive buy outs. LABU Technical Analysis: Bullish Harmonic Gartley pattern and close to 52-week low. 1-year Gartley pattern should move LABU stock price back up to around $40 level (resistance) where we will be watching for a potential breakout CCI measured "oversold" with the end of September pullback, CCI-slope is now trending higher, This last pullback also measures a double bottom (data points are from Christmas 2018 and present) Intra-day bullish RSI divergence, Daily RSI trending higher; the MS Signal recently flipped green as of 10/1/2019 and is still indicating a nice swing opportunity to come. Three-drives pattern bouncing toward resistance concurrent with double bottom and Gartley pattern. Look for the support level (marked (x)) to hold. See conclusion here ! Please like and follow so we can continue finding awesome charts/ trades. For more pre-researched Biotech trade-ideas click and visit us at MS Money Moves . Thanks in advance everyone!! Disclosure: I do not own LABU, I may buy or sell within the next 48 hours. This is not a recommendation to buy or sell. Please do your homework before investing.
AMEX:LABULong
by follow_the_money
2
Harmonic Cypher Final Data from Robarts study coming September, in Spain. To learn more about TAEUS, click here . Company ran by ex-GE executives. TAM is in the Billions of Dollars $$. Low float. Recently broke long-term down trend. Daily, Weekly, Monthly charts #BULLISH. Fibonacci convergence at 618 fib (projection) into September time frame. Follow me on twitter and instagram @ #VolatilityWatch Disclaimer: I am long NDRA. This is not a recommendation to buy or sell. Please do your homework before investing.
NASDAQ:NDRALong
by follow_the_money